About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT05621993

An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia

This is a multicenter, ambispective observational cohort study. The patients with corona virus disease 2019 (COVID-19) will be included in the study. The patients will be divided into 4 groups accordi...

Lead sponsor: Qianfoshan Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Qian Qi, Dr.

CONTACT

+86 13706380314 qiqianqlh@163.com

Sponsors

Lead Sponsor

Qianfoshan Hospital

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients with confirmed diagnosis of COVID-19 pneumonia
•Patients with the ability to take medication orally

Exclusion Criteria

•Severe vomiting and difficulty in taking oral medication or ingestion of drugs after oral administration
•Suspected or confirmed active systemic infection other than COVID-19 pneumonia
•Pregnant or lactating women
•Patients with mental disorders
•Patients with severe liver damage
•Patients who are treated with small molecule drugs such as Nirmatrelvir Tablets/Ritonavir Tablets(co-packaged)
•Patients who are treated with RNA-dependent RNA polymerase (RDRP) inhibitors (Junshipharma VV116, Ascletis Pharma Inc. Asc10, Kexing biopharm Shen26, and Molnupiravir).

Related studies

Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine

NCT06402318 · COVID-19, SARS CoV 2 Virus, and more

Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure

NCT05562505 · Mechanical Ventilation Complication, Hypoxemia, and more

Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection

NCT06490744 · COVID-19 Respiratory Infection

RECRUITINGPhase 2/3

Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia

NCT05706454 · COVID-19 Pneumonia, COVID-19 Respiratory Infection

Active Not Recruiting

Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2

NCT05040659 · Anosmia, Asymptomatic COVID-19, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 3, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment500

Start dateNov 2022

Last updatedOct 3, 2023

Condition

COVID-19 Respiratory Infection

Locations shown

Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China

Jinan, Shandong

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 3, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions